0 likes | 191 Views
Rational Competition Policy and Hatch-Waxman Reverse Settlement Payments. Prof. David W. Opderbeck Seton Hall University Law School Gibbons Institute of Law, Science & Technology. Background. FDA new drug approval process requires multiple phases of clinical testing (NDA)
E N D